Cancer Morbidity and Mortality
Cancer Morbidity and Mortality

Cancer Morbidity and Mortality

by Richard Mitchell, MD, PhD

Tumors induce changes throughout the body, such as an increase in coagulability, electrolyte dysregulation, and antibody formation leading to paraneoplastic syndromes. In paraneoplastic syndromes, the malignant cells do not directly cause symptoms related to metastasis; rather, they generate autoantibodies, cytokines, hormones, or peptides that affect multiple organ systems. In addition, the treatment of cancer often targets rapidly dividing cells or, in some cases, the immune system, which can lead to significant morbidity from unintended side effects. All of these factors contribute to why cancer is such a devastating diagnosis with often poor outcomes.

Course Details

  • Videos 15
  • Duration 1:06 h
  • Quiz questions 30
  • Concept Pages 4


Your Educators of course Cancer Morbidity and Mortality

 Richard Mitchell, MD, PhD

Richard Mitchell, MD, PhD

Dr. Richard N. Mitchell is the Lawrence J. Henderson Professor of Pathology and Health Sciences and Technology, at Harvard Medical School in Massachusetts, USA.

He obtained his PhD in Cell Biology and Immunology from Rockefeller University in 1980, and his MD from Harvard Medical School in 1984. Currently, he is Program Director of the Health Sciences and Technology Education and Curriculum at Harvard Medical School.

Due to his achievements, he earned the ASIP Robbins Distinguished Educator Award in 2013.

Within Lecturio, Dr. Mitchell teaches courses on Pathology.

User reviews

5,0 of 5 stars
5 Stars
4 Stars
3 Stars
2 Stars
1  Star